论文部分内容阅读
众所周知,开发新药物耗时耗资,而发现已批准上市药物的新功效,具有广泛的经济学价值和治疗学价值。伊曲康唑临床应用于真菌病治疗已近30年,其安全性和疗效广受认可。近年来,人们陆续发现伊曲康唑具有抗肿瘤等新作用,其强大的生物学效应和初步的临床应用效果吸引了医学界的广泛关注。本文旨在总结伊曲康唑抗肿瘤作用的研究现状,并就相关问题浅谈一些认识。
It is known to all that it costs time and money to develop new drugs and discover the new efficacy of approved drugs on the market with a wide range of economic and therapeutic values. Itraconazole clinical application for fungal disease treatment for nearly 30 years, its safety and efficacy widely recognized. In recent years, people gradually discovered that itraconazole has antitumor and other new effects, its strong biological effects and preliminary clinical application results have attracted widespread medical attention. This article aims to summarize the current research status of itraconazole antitumor effect, and to talk about some related issues.